These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2112336)

  • 21. Sustained beneficial effect of a seventy-two hour intravenous infusion of nitroglycerin in patients with severe chronic congestive heart failure.
    Dupuis J; Lalonde G; Lebeau R; Bichet D; Rouleau JL
    Am Heart J; 1990 Sep; 120(3):625-37. PubMed ID: 2117845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized, double-blind, placebo-controlled study of ascorbate on the preventive effect of nitrate tolerance in patients with congestive heart failure.
    Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
    Circulation; 1998 Mar; 97(9):886-91. PubMed ID: 9521337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine.
    Dupuis J; Lalonde G; Lemieux R; Rouleau JL
    J Am Coll Cardiol; 1990 Oct; 16(4):923-31. PubMed ID: 1976661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial natriuretic peptide in severe heart failure: response to controlled changes in atrial pressures during intravenous nitroglycerin therapy.
    Lewis BS; Makhoul N; Dakak N; Flugelman MY; Yechiely H; Halon DA; Kahana L
    Am Heart J; 1992 Oct; 124(4):1009-16. PubMed ID: 1388322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specialized delivery systems for intravenous nitroglycerin. Are they necessary?
    Young JB; Pratt CM; Farmer JA; Luck JC; Fennell WH; Roberts R
    Am J Med; 1984 Jun; 76(6A):27-37. PubMed ID: 6430075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained beneficial hemodynamic responses to large doses of transdermal nitroglycerin in congestive heart failure and comparison with intravenous nitroglycerin.
    Rajfer SI; Demma FJ; Goldberg LI
    Am J Cardiol; 1984 Jul; 54(1):120-5. PubMed ID: 6430054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained hemodynamic effects with therapeutic doses of intravenous nitroglycerin in congestive heart failure.
    Natarajan D; Khurana TR; Karhade V; Nigam PD
    Am J Cardiol; 1988 Aug; 62(4):319-21. PubMed ID: 3135741
    [No Abstract]   [Full Text] [Related]  

  • 28. Arterial-venous nitroglycerin gradient during intravenous infusion in man.
    Armstrong PW; Moffat JA; Marks GS
    Circulation; 1982 Dec; 66(6):1273-6. PubMed ID: 6814785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hemodynamic and clinical effects and treatment tolerance with low-dose iv amrinone in patients with refractory heart failure: a multicenter study. The Group for Research on Amrinone in the Treatment of Refractory Heart Failure].
    Dei Cas L; Metra M; Nodari S; Raddino R; Visioli O
    Cardiologia; 1991 May; 36(5):363-71. PubMed ID: 1756541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in atrial natriuretic factor during preload reduction with nitroglycerin in patients with congestive heart failure.
    Keller N; Sykulski R; Thamsborg G; Storm T; Larsen J
    Clin Physiol; 1988 Feb; 8(1):57-64. PubMed ID: 2964972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemodynamic and neurohumoral effects of flosequinan in severe heart failure: similarities and differences compared with intravenous nitroglycerin therapy.
    Dakak N; Makhoul N; Merdler A; Yechiely H; Kahana L; Halon DA; Schneeweiss A; Lewis BS
    Eur Heart J; 1993 Jun; 14(6):836-44. PubMed ID: 8325314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic effects of dopexamine hydrochloride infusions of 48 to 72 hours' duration for severe congestive heart failure.
    Gollub SB; Emmot WW; Johnson DE; Sights KA; Wilson DB; Vacek JL; Hassanein K
    Am J Cardiol; 1988 Aug; 62(5):83C-88C. PubMed ID: 3407599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure.
    Roth A; Kulick D; Freidenberger L; Hong R; Rahimtoola SH; Elkayam U
    J Am Coll Cardiol; 1987 Apr; 9(4):858-64. PubMed ID: 3104435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic effects of intermittent transdermal nitroglycerin in chronic congestive heart failure.
    Sharpe N; Coxon R; Webster M; Luke R
    Am J Cardiol; 1987 Apr; 59(8):895-9. PubMed ID: 3103412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of intravenous nitroglycerin on hemodynamics of congestive heart failure.
    Pitt WA; Friedman RG; Gross SA; Glassman J; Keating EC; Mazur JH
    Angiology; 1982 May; 33(5):294-301. PubMed ID: 6805373
    [No Abstract]   [Full Text] [Related]  

  • 36. Beneficial effects of dopamine combined with intravenous nitroglycerin on hemodynamics in patients with severe left ventricular failure.
    Loeb HS; Ostrenga JP; Gaul W; Witt J; Freeman G; Scanlon P; Gunnar RM
    Circulation; 1983 Oct; 68(4):813-20. PubMed ID: 6413087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure.
    Bauer JA; Fung HL
    J Pharmacol Exp Ther; 1991 Jan; 256(1):249-54. PubMed ID: 1899118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of intravenous nitroglycerin on hemodynamics in neonates with refractory congestive heart failure or PFC.
    Tamura M; Kawano T
    Acta Paediatr Jpn; 1990 Jun; 32(3):291-8. PubMed ID: 2122634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative evaluation of isosorbide-5-mononitrate and nitroglycerin in chronic congestive heart failure.
    Schneeweiss A
    Am J Cardiol; 1988 Mar; 61(9):19E-21E. PubMed ID: 3126632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Captopril does not prevent nitroglycerin tolerance in heart failure.
    Dupuis J; Lalonde G; Bichet D; Rouleau JL
    Can J Cardiol; 1990 Sep; 6(7):281-6. PubMed ID: 2121325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.